# Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)

> **NCT02464709** · PHASE4 · COMPLETED · sponsor: **Joint Authority for Päijät-Häme Social and Health Care** · enrollment: 72 (actual)

## Conditions studied

- Actinic Keratosis
- Natural Daylight Photodynamic Therapy

## Interventions

- **DRUG:** Aminolevulinic Acid
- **DRUG:** Methyl 5-aminolevulinate

## Key facts

- **NCT ID:** NCT02464709
- **Lead sponsor:** Joint Authority for Päijät-Häme Social and Health Care
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2019-08-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02464709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02464709, "Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02464709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*